Alzheimer's Disease is a neurological condition primarily affecting cognitive function, leading to memory loss, confusion, and behavioral changes.

Over time, it progresses, impacting daily activities and requiring long-term care. Originally perceived as a straightforward cognitive disorder, research has increasingly highlighted the complex interplay of genetic, neurobiological, and environmental factors involved in its development.

This deeper understanding has guided the creation of therapies that not only target symptoms but also address the underlying mechanisms of the disease.

iNGENū's team of experienced researchers and clinicians is dedicated to advancing Alzheimer's research. Through innovative trial designs and patient-focused strategies, we are committed to accelerating the development of new treatments that can improve the lives of those affected by Alzheimer's Disease.